(Q50525310)

English

Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema.

scientific article published in February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

1 reference

based on heuristic

inferred from title

author name string

Chang WS

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

Lomas DA

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

language of work or name

0 references

publication date

1 February 1998

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

Journal of Biological Chemistry

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

273

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

3695-3701

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

Human plasma proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Synthesis of pppGpN typs dinucleotide derivatives: the 5′ end sequence of some RNAs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Human α-1-antichymotrypsin: purification and properties

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Probing serpin reactive-loop conformations by proteolytic cleavage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Preparation and characterization of latent alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmi

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Structural alterations in alpha 1-antichymotrypsin from normal and acute phase human plasma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

The microheterogeneity of desialylated alpha 1-antichymotrypsin: the occurrence of two amino-terminal isoforms, one lacking a His-Pro dipeptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

[Characterization of alpha-1-X-glycoprotein as chymotrypsin inhibitor of human plasma]

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Purification and characterization of alpha 1-antichymotrypsin from human pleural fluid and human serum

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.6.3695

21 January 2018

Identifiers

10.1074/JBC.273.6.3695

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/9452500

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50525310&oldid=1542566051"